Know Labs Inc. approved a reverse stock split at a 1-for-40 ratio, reducing authorized shares from 300 million to 7.5 million and outstanding shares from approximately 112.4 million to about 2.8 million, effective February 19, 2025, to meet NYSE American listing requirements.